R. V. van Schaik

发表

I. Brandslund, D. Gurwitz, J. Lunshof, 2019, Pharmacogenomics.

M. Whirl‐Carrillo, K. Sangkuhl, T. Klein, 2018, Clinical pharmacology and therapeutics.

A. V. van Kuilenburg, H. Rosing, J. Beijnen, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

B. Peters, R. Drmanac, G. Patrinos, 2014, Pharmacogenomics.

U. Christians, H. Colom, V. Haufroid, 2019, Therapeutic drug monitoring.

R. V. van Schaik, J. Swen, M. Nijenhuis, 2021, European Journal of Human Genetics.

R. V. van Schaik, T. van Gelder, P. R. Bakker, 2021, Frontiers in Pharmacology.

A. Serretti, M. Ingelman-Sundberg, D. Müller, 2020, Frontiers in Pharmacology.

H. Guchelaar, R. V. van Schaik, J. Swen, 2019, European Journal of Human Genetics.

H. Hoek, R. V. van Schaik, P. V. van Harten, 2018, Front. Psychiatry.

R. V. van Schaik, V. Deneer, 2013, Methods in molecular biology.

Mark I. McCarthy, Alison A. Motsinger-Reif, John S. Witte, 2016, Nature Genetics.

Nawaid Usmani, Suzanne Chambers, Martin Eklund, 2018, Nature Communications.

F. Innocenti, R. V. van Schaik, S. Paugh, 2013, Methods in molecular biology.

M. Smid, J. Martens, R. Mathijssen, 2015, Pharmacogenomics.

H. Guchelaar, R. V. van Schaik, H. V. van Laarhoven, 2015, Therapeutic drug monitoring.

M. Smid, E. Wiemer, J. Martens, 2013, Clinical Cancer Research.

V. Haufroid, S. Clarke, R. Mathijssen, 2013, Pharmacogenetics and genomics.

E. Wiemer, A. Jager, R. Mathijssen, 2015, Breast Cancer Research and Treatment.

S. V. van Dijk, R. V. van Schaik, J. V. van Leeuwen, 2012, Bone.

J. Nauta, D. Hesselink, R. V. van Schaik, 2008, Pharmacogenomics.

H. Comber, G. Cavalleri, R. V. van Schaik, 2015, Renal failure.

R. V. van Schaik, J. Lindemans, J. N. van den Anker, 2002, Clinical chemistry.

E. Wiemer, J. Verweij, E. de Jonge, 2015, British journal of clinical pharmacology.

G. Schaaf, Jeroen A. A. Demmers, L. Verdijk, 2016, Circulation. Cardiovascular genetics.

Corey M. Carlson, D. Chan, L. Sokoll, 2012, Clinica chimica acta; international journal of clinical chemistry.

G. Patrinos, R. V. van Schaik, N. Maniadakis, 2017, Omics : a journal of integrative biology.

J. Verweij, W. Loos, R. V. van Schaik, 2006, Cancer biology & therapy.

A. Hofman, B. Stricker, H. Tiemeier, 2009, Pharmacogenomics.

A. Hofman, R. V. van Schaik, A. Vulto, 2009, British journal of clinical pharmacology.

A. Hofman, B. Stricker, R. V. van Schaik, 2008, British journal of clinical pharmacology.

H. Pols, S. Lamberts, R. V. van Schaik, 2005, The Journal of clinical endocrinology and metabolism.

A. V. van Kuilenburg, J. Schellens, H. Rosing, 2019, European journal of cancer.

S. Sleijfer, J. Verweij, A. Sparreboom, 2010, The oncologist.

D. Hesselink, R. V. van Schaik, T. van Gelder, 2020, British journal of clinical pharmacology.

D. Hesselink, R. Mathijssen, R. V. van Schaik, 2019, Journal of Immunotherapy for Cancer.

R. Zietse, E. Hoorn, D. Hesselink, 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

D. Hesselink, R. V. van Schaik, R. Schaik, 2016, Expert opinion on drug metabolism & toxicology.

M. Tilanus-Linthorst, J. Grutters, R. V. van Schaik, 2009, Clinical biochemistry.

W. Weimar, D. Hesselink, R. V. van Schaik, 2013, Therapeutic drug monitoring.

R. V. van Schaik, K. Pondman, J. van der Weide, 2018, Drug metabolism and personalized therapy.

R. V. van Schaik, K. Allegaert, S. Simons, 2022, Pharmacogenomics and personalized medicine.

D. Hesselink, R. V. van Schaik, T. van Gelder, 2004, Therapeutic drug monitoring.

V. Haufroid, D. Hesselink, R. V. van Schaik, 2013, Pharmacogenomics.

R. Mathijssen, R. V. van Schaik, S. Bins, 2016, Pharmacogenomics.

I. Brandslund, C. Di Resta, M. Schwab, 2018, Clinical chemistry and laboratory medicine.

D. Tibboel, M. V. van Lipzig, H. Wortelboer, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

R. Danesi, R. V. van Schaik, R. Schaik, 2016, Pharmacological research.

C. Seynaeve, J. Verweij, J. Beijnen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

R. Brosens, R. V. van Schaik, M. van Fessem, 2001, Clinical chemistry.

R. D. de Winter, M. Simoons, P. van der Harst, 2020, Journal of the American Heart Association.

A. Isaacs, E. Steegers, R. Steegers-Theunissen, 2011, American journal of obstetrics and gynecology.

R. V. van Schaik, J. Lindemans, I. P. van der Heiden, 2004, Clinical chemistry.

Y. Assaraf, A. Dingemans, R. Mathijssen, 2022, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

J. Aerts, W. Dinjens, C. H. van der Leest, 2020, Cancers.

D. Tibboel, R. V. van Schaik, C. Knibbe, 2016, American journal of respiratory and critical care medicine.

D. Tibboel, R. V. van Schaik, K. Allegaert, 2016, Therapeutic drug monitoring.

R. V. van Schaik, J. Lindemans, C. Cobbaert, 1999, Clinical chemistry.

D. Nieboer, J. Devlin, R. V. van Schaik, 2020, Journal of critical care.

J. Roos‐Hesselink, J. Cheng, I. Kardys, 2015, International journal of cardiology.

D. Hesselink, R. Mathijssen, R. V. van Schaik, 2021, Frontiers in Genetics.

D. Hesselink, R. V. van Schaik, T. van Gelder, 2014, British journal of clinical pharmacology.

S. Sleijfer, H. Gelderblom, R. Mathijssen, 2018, Clinical Pharmacokinetics.

M. D. de Bruin‐Weller, R. V. van Schaik, J. Schaft, 2017, The Journal of dermatological treatment.

R. V. van Schaik, S. Bogaerts, D. Vinkers, 2014, Criminal behaviour and mental health : CBMH.

M. Look, R. Mathijssen, R. V. van Schaik, 2016, Pharmacogenomics.

A. V. van Kuilenburg, J. Schellens, R. Danesi, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

A. V. van Kuilenburg, J. Schellens, H. Guchelaar, 2017, JCO precision oncology.

A. Addeo, R. Danesi, R. V. van Schaik, 2019, Pharmacogenomics.

R. V. van Schaik, R. V. van Schaik, 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

R. V. van Schaik, B. D. de Winter, M. Mulder, 2019, British journal of clinical pharmacology.

A. Addeo, R. Danesi, R. V. van Schaik, 2019, Pharmacogenomics.

A. Hofman, A. Uitterlinden, J. Witteman, 2007, Pharmacogenetics and genomics.

P. Sonneveld, B. van der Holt, R. V. van Schaik, 2007, The Journal of antimicrobial chemotherapy.

M. Neumaier, H. Guchelaar, R. V. van Schaik, 2019, Clinica chimica acta; international journal of clinical chemistry.

C. Mamotte, R. V. van Schaik, M. Pazzagli, 2010, Clinical chemistry and laboratory medicine.

D. Hesselink, R. V. van Schaik, T. van Gelder, 2013, British journal of clinical pharmacology.

R. V. van Schaik, M. Blonk, D. Burger, 2016, Antiviral therapy.

G. Koren, S. Mital, R. V. van Schaik, 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

E. Steegers, R. Steegers-Theunissen, R. V. van Schaik, 2009, American journal of medical genetics. Part A.

R. Mathijssen, R. V. van Schaik, S. Bins, 2022, JCO precision oncology.

R. Mathijssen, P. de Bruijn, R. V. van Schaik, 2016, Clinical Pharmacokinetics.

E. Kuipers, R. V. van Schaik, R. Mathôt, 2008, British journal of clinical pharmacology.

R. V. van Schaik, M. van Fessem, B. Philips, 2015, Intensive Care Medicine Experimental.

R. V. van Schaik, S. Willemsen, L. van Rossem, 2022, Clinical chemistry and laboratory medicine.

A. Jager, R. Mathijssen, R. V. van Schaik, 2022, Therapeutic advances in medical oncology.

D. Tibboel, R. V. van Schaik, G. Naulaers, 2008, British journal of anaesthesia.

J. H. van der Kolk, R. V. van Schaik, J. V. van Leeuwen, 2008, Veterinary Record.

Fernando Rivadeneira, Albert Hofman, Martina Teichert, 2009, Human molecular genetics.

N. V. Chirkova, Rostyslav V Bubnov, Y. Benjamini, 2016, EPMA Journal.

P. Verhagen, R. V. van Schaik, G. V. van Leenders, 2007, The Journal of urology.

A. Hofman, A. Uitterlinden, R. V. van Schaik, 2010, Pharmacoepidemiology and drug safety.

S. Sleijfer, J. Aerts, C. H. van der Leest, 2020, Journal for immunotherapy of cancer.

M. Neely, R. V. van Schaik, J. N. van den Anker, 2010, Therapeutic drug monitoring.

D. Hesselink, R. V. van Schaik, R. V. Schaik, 2012, Molecular Diagnosis & Therapy.

J. Jakobsson, M. Ingelman-Sundberg, M. Hiratsuka, 2011, European Journal of Clinical Pharmacology.

J. Nauta, R. V. van Schaik, M. Ackermans, 2016, Therapeutic drug monitoring.

A. Jager, R. Danesi, R. Mathijssen, 2022, Cancer treatment reviews.

K. D. Sørensen, O. Andreassen, A. Dale, 2021, Prostate Cancer and Prostatic Diseases.

A. Hofman, A. Uitterlinden, B. Stricker, 2008, Pharmacogenetics and genomics.

G. H. Bruun, S. Baker, A. Gibson, 2012, Clinical Cancer Research.

J. Verweij, W. Graveland, A. Sparreboom, 2004, Journal of the National Cancer Institute.

J. Verweij, S. Clarke, M. Carducci, 2004, Clinical Cancer Research.

J. Verweij, A. Sparreboom, R. Mathijssen, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

R. Mathijssen, R. V. van Schaik, 2006, European journal of cancer.

M. Racchi, S. Govoni, G. Ranzani, 2013, Journal of pain research.

P. Ahmad-Nejad, K. C. Chan, C. Mamotte, 2017, Clinica chimica acta; international journal of clinical chemistry.

G. Curigliano, R. Danesi, S. Fogli, 2019, Cancer treatment reviews.

P. Sonneveld, E. Wiemer, R. V. van Schaik, 2006, Clinical pharmacology and therapeutics.

Manousos E. Kambouris, Vita Dolzan, Alessio Squassina, 2016, Public Health Genomics.

W. Weimar, D. Hesselink, R. V. van Schaik, 2012, Clinica chimica acta; international journal of clinical chemistry.

D. Hesselink, R. V. van Schaik, T. van Gelder, 2005, Pharmacogenomics.

John T. Wei, D. Chan, W. Catalona, 2015, The Journal of urology.

M. D. de Bruin‐Weller, R. V. van Schaik, F. Garritsen, 2018, The Journal of dermatological treatment.

D. Hesselink, R. V. van Schaik, B. D. de Winter, 2022, European Journal of Drug Metabolism and Pharmacokinetics.

R. Zietse, E. Hoorn, D. Hesselink, 2014, Pharmacogenomics.

M. Huibers, D. Hesselink, R. V. van Schaik, 2018, Therapeutic drug monitoring.

R. Zietse, E. Hoorn, D. Hesselink, 2020 .

R. V. van Schaik, 2005, Investigational new drugs.

D. Tibboel, R. V. van Schaik, S. D. de Wildt, 2017, Clinical chemistry.

I. Brandslund, C. Di Resta, M. Schwab, 2015, Clinica chimica acta; international journal of clinical chemistry.

M. Postma, J. Maring, P. Jansen, 2019, Journal of clinical psychopharmacology.

P. Sonneveld, R. V. van Schaik, A. van der Padt, 2006, The Netherlands journal of medicine.

E. Wiemer, J. Verweij, B. van der Holt, 2013, Clinical Cancer Research.

J. D. de Fijter, D. Hesselink, N. Lloberas, 2019, British journal of clinical pharmacology.

W. Weimar, D. Hesselink, R. V. van Schaik, 2011, Therapeutic drug monitoring.

R. V. van Schaik, A. Oranje, R. Heide, 2006, Dermatology.

H. Gréen, R. V. van Schaik, R. Kronstrand, 2018, Pharmacology research & perspectives.

Micheline Piquette-Miller, Gouri Mukerjee, Andrea Huston, 2018, npj Genomic Medicine.

D. Tibboel, R. V. van Schaik, S. D. de Wildt, 2016, Pain.

R. V. van Lingen, D. Tibboel, R. V. van Schaik, 2014, Pharmacogenomics.

A. Hofman, J. Witteman, R. V. van Schaik, 2008, Arteriosclerosis, thrombosis, and vascular biology.

A. Jager, R. Mathijssen, R. V. van Schaik, 2019, Cancers.

A. V. van Kuilenburg, J. Maring, J. Schellens, 2022, Clinical pharmacology and therapeutics.

V. Haufroid, R. Mathijssen, M. Joerger, 2023, ESMO open.

R. Mathijssen, R. V. van Schaik, S. Bins, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

R. V. van Schaik, V. Manolopoulos, G. Ragia, 2014, Experimental and Clinical Endocrinology & Diabetes (Barth).

G. Siest, R. V. van Schaik, A. Llerena, 2011, Pharmacogenomics (London).

K. Nasserinejad, M. Hillegers, R. V. van Schaik, 2020, British journal of clinical pharmacology.

A. Jager, R. Mathijssen, R. V. van Schaik, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

F. T. ten Cate, J. Saris, R. V. van Schaik, 2006, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Jyotishman Pathak, Panu Somervuo, Judit Kumuthini, 2016, Pharmacogenomics.

V. Haufroid, J. D. de Fijter, K. Budde, 2013, Therapeutic drug monitoring.

J. Goldstein, R. V. van Schaik, I. P. van der Heiden, 2007, Drug Metabolism and Disposition.

Roland P. Bühlmann, P. Deloukas, P. Froguel, 2017, Drug metabolism and personalized therapy.

A. Dingemans, R. Mathijssen, R. V. van Schaik, 2023, JACC. CardioOncology.

R. V. van Schaik, J. Swen, M. Nijenhuis, 2022, European Journal of Human Genetics.

A. Hofman, J. Coebergh, J. Dieleman, 2009, The Netherlands journal of medicine.

T. Monteyne, D. Hemelsoet, R. V. van Schaik, 2021, International journal of laboratory hematology.

R. Dorfman, R. V. van Schaik, B. Kabakchiev, 2018, npj Genomic Medicine.

K. D. Sørensen, Ali Amin Al Olama, H. Ostrer, 2019, Nature Communications.

B. Stricker, R. V. van Schaik, M. Becker, 2010, Pharmacogenetics and genomics.

Mathias M. Müller, C. Auffray, G. Siest, 2015, Pharmacogenomics.

R. Mathijssen, R. V. van Schaik, A. Goey, 2019, Pharmacogenomics.

G. Siest, D. Gurwitz, B. Melichar, 2014, Pharmacogenomics.

H. Gelderblom, R. Mathijssen, P. de Bruijn, 2023, Clinical Pharmacokinetics.

R. Mathijssen, R. V. van Schaik, S. Bins, 2023, Clinical Pharmacokinetics.

D. Hesselink, R. V. van Schaik, T. van Gelder, 2013, British journal of clinical pharmacology.

D. Tibboel, R. V. van Schaik, S. D. de Wildt, 2017, Clinical chemistry.

B. Peters, R. Drmanac, G. Patrinos, 2014, Pharmacogenomics.

K. D. Sørensen, H. Ostrer, T. Sellers, 2018, Nature Communications.

U. Broeckel, R. V. van Schaik, A. Gaedigk, 2023, The Journal of molecular diagnostics : JMD.

Vasilios Fragoulakis, Christina Mitropoulou, Ron H van Schaik, 2016, Omics : a journal of integrative biology.

P. Ahmad-Nejad, C. Mamotte, R. V. van Schaik, 2018, Clinical chemistry and laboratory medicine.